Literature DB >> 14500531

Sequence and expression analysis of virB9 of the type IV secretion system of Ehrlichia canis strains in ticks, dogs, and cultured cells.

Suleyman Felek1, Haibin Huang, Yasuko Rikihisa.   

Abstract

Ehrlichia canis virB9 was cloned and expressed. The sequences of virB9 from six geographic locations were identical. virB9 was transcribed by E. canis in dogs, ticks, and cell culture. Infected dogs had antibodies to recombinant VirB9, indicating that VirB9 was produced by E. canis in dogs and was antigenic.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14500531      PMCID： PMC201090          DOI： 10.1128/IAI.71.10.6063-6067.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  27 in total

Review 1.  Type IV secretion and Brucella virulence.

Authors:  Maria Laura Boschiroli; Safia Ouahrani-Bettache; Vincent Foulongne; Sylvie Michaux-Charachon; Gisele Bourg; Annick Allardet-Servent; Chantal Cazevieille; Jean-Phillipe Lavigne; Jean Pierre Liautard; Michel Ramuz; David O'Callaghan
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

2.  Identification of Brucella spp. genes involved in intracellular trafficking.

Authors:  R M Delrue; M Martinez-Lorenzo; P Lestrate; I Danese; V Bielarz; P Mertens; X De Bolle; A Tibor; J P Gorvel; J J Letesson
Journal:  Cell Microbiol       Date:  2001-07       Impact factor: 3.715

3.  Sensitive detection of Ehrlichia chaffeensis in cell culture, blood, and tick specimens by reverse transcription-PCR.

Authors:  S Felek; A Unver; R W Stich; Y Rikihisa
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  Identification of genes required for chronic persistence of Brucella abortus in mice.

Authors:  P C Hong; R M Tsolis; T A Ficht
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Molecular and antigenic comparison of Ehrlichia canis isolates from dogs, ticks, and a human in Venezuela.

Authors:  A Unver; M Perez; N Orellana; H Huang; Y Rikihisa
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

6.  Bacterial secrets of secretion: EuroConference on the biology of type IV secretion processes.

Authors:  Christian Baron; David OCallaghan; Erich Lanka
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

7.  Elevated temperature differentially affects virulence, VirB protein accumulation, and T-pilus formation in different Agrobacterium tumefaciens and Agrobacterium vitis strains.

Authors:  C Baron; N Domke; M Beinhofer; S Hapfelmeier
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

8.  Essential role of the VirB machinery in the maturation of the Brucella abortus-containing vacuole.

Authors:  D J Comerci; M J Martínez-Lorenzo; R Sieira; J P Gorvel; R A Ugalde
Journal:  Cell Microbiol       Date:  2001-03       Impact factor: 3.715

Review 9.  From genome to vaccine: in silico predictions, ex vivo verification.

Authors:  A S De Groot; A Bosma; N Chinai; J Frost; B M Jesdale; M A Gonzalez; W Martin; C Saint-Aubin
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

10.  Characterization and transcriptional analysis of gene clusters for a type IV secretion machinery in human granulocytic and monocytic ehrlichiosis agents.

Authors:  Norio Ohashi; Ning Zhi; Quan Lin; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441
View more
  14 in total

1.  Differentially expressed and secreted major immunoreactive protein orthologs of Ehrlichia canis and E. chaffeensis elicit early antibody responses to epitopes on glycosylated tandem repeats.

Authors:  C Kuyler Doyle; Kimberly A Nethery; Vsevolod L Popov; Jere W McBride
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 2.  Biological diversity of prokaryotic type IV secretion systems.

Authors:  Cristina E Alvarez-Martinez; Peter J Christie
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

Review 3.  Phylogenomics reveals a diverse Rickettsiales type IV secretion system.

Authors:  Joseph J Gillespie; Kelly A Brayton; Kelly P Williams; Marco A Quevedo Diaz; Wendy C Brown; Abdu F Azad; Bruno W Sobral
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

Review 4.  Type IV secretion in the obligatory intracellular bacterium Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa; Mingqun Lin; Hua Niu
Journal:  Cell Microbiol       Date:  2010-07-28       Impact factor: 3.715

5.  Association and evidence for linked recognition of type IV secretion system proteins VirB9-1, VirB9-2, and VirB10 in Anaplasma marginale.

Authors:  Kaitlyn Morse; Junzo Norimine; Guy H Palmer; Eric L Sutten; Timothy V Baszler; Wendy C Brown
Journal:  Infect Immun       Date:  2011-10-28       Impact factor: 3.441

6.  The genome of the obligately intracellular bacterium Ehrlichia canis reveals themes of complex membrane structure and immune evasion strategies.

Authors:  K Mavromatis; C Kuyler Doyle; A Lykidis; N Ivanova; M P Francino; P Chain; M Shin; S Malfatti; F Larimer; A Copeland; J C Detter; M Land; P M Richardson; X J Yu; D H Walker; J W McBride; N C Kyrpides
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

Review 7.  Anaplasma phagocytophilum and Ehrlichia chaffeensis type IV secretion and Ank proteins.

Authors:  Yasuko Rikihisa; Mingqun Lin
Journal:  Curr Opin Microbiol       Date:  2010-01-05       Impact factor: 7.934

Review 8.  Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Vet Parasitol       Date:  2009-09-19       Impact factor: 2.738

9.  VirB12 is a serological marker of Brucella infection in experimental and natural hosts.

Authors:  Hortensia G Rolán; Andreas B den Hartigh; Melissa Kahl-McDonagh; Thomas Ficht; L Garry Adams; Renée M Tsolis
Journal:  Clin Vaccine Immunol       Date:  2007-12-12

10.  Anaplasma marginale type IV secretion system proteins VirB2, VirB7, VirB11, and VirD4 are immunogenic components of a protective bacterial membrane vaccine.

Authors:  Eric L Sutten; Junzo Norimine; Paul A Beare; Robert A Heinzen; Job E Lopez; Kaitlyn Morse; Kelly A Brayton; Joseph J Gillespie; Wendy C Brown
Journal:  Infect Immun       Date:  2010-01-11       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.